Simultaneous Boron Ion-Channel/Growth Factor Receptor Activation for Enhanced Vascularization

Area of Science:

• Molecular biology
• Biochemistry
• Physiology

Background:

• Boron is vital for metabolism, with its levels controlled by the NaBC1 ion channel.
• NaBC1 mutations are linked to corneal dystrophies, like Harboyan syndrome.
• Angiogenesis, the formation of new blood vessels, is crucial for development and disease.

Purpose of the Study:

• To propose a 3D molecular model for the NaBC1 ion channel.
• To investigate the role of NaBC1 in angiogenesis, particularly in conjunction with VEGFR.
• To explore a novel mechanism for vascularization involving NaBC1 and VEGF.

Main Methods:

• Development of a 3D molecular model for NaBC1.
• In vitro studies using Human Umbilical Vein Endothelial Cells (HUVEC) to assess vascularization potential.
• In vivo assays, including a chorioallantoic membrane assay, to evaluate angiogenesis.
• Experiments involving stimulation of NaBC1 and VEGFR, with and without boron and VEGF, and blockade of NaBC1.

Main Results:

• Simultaneous stimulation of NaBC1 and VEGFR promotes angiogenesis in vitro and in vivo, even at very low VEGF concentrations.
• Boron, in conjunction with VEGF, significantly enhances HUVEC organization and sprouting, an effect dependent on NaBC1 activity.
• NaBC1-stimulated angiogenesis occurs via PI3k-independent pathways and does not require α5β1/αvβ3 integrin binding.
• A novel mechanism of vascularization involving crosstalk and colocalization between NaBC1 and VEGFR is identified.

Conclusions:

• A new mechanism for angiogenesis involving NaBC1 and VEGFR crosstalk has been elucidated.
• Boron administration, leveraging endogenous VEGF, can effectively promote in vivo vascularization.
• This finding has significant translational potential for therapeutic strategies aimed at enhancing blood vessel formation.